Novo Nordisk USA
Novo Nordisk Pharmaceutical Industries manufactures insulin products for individuals with diabetes. The products manufactured at the Clayton plant are marketed in North America, Europe, New Zealand and Australia.

Year Established: 1993
Stock Ticker: NVO
Exchange: NYSE